Prot # 003-00: Randomized, Active-Controlled, Dose-Ranging Estimation Study to Evaluate the Safety, Tolerability, and Efficacy of Different Regimens of MK-5172 When Administered Concomitantly with Peginterferon alfa-2b and Ribavirin in Treatment-Naive Pat

Project: Research project

Project Details

StatusFinished
Effective start/end date7/27/117/27/14

Funding

  • Merck Sharp & Dohme Corporation (Prot # 003-00)